Morning Preview: $JCP Upgraded, Fuel Cell Mania, And Today’s Winner In Biotech

Once again both $PLUG and $BLDP are the top trending tickers on StockTwits. The two fuel cell companies have caught just about everyone’s attention over the last few weeks and yesterday in our market wrap @ChicagoSean wrote why this is both incredibly exciting, but also terrifying.

The simple fact is $PLUG has gone from 12 cents to 12 dollars in 12 months and yesterday $PLUG’s market cap climbed above $1 billion for the first time since 2000. Below we’ve shared two charts that highlight total message volume on the $PLUG and $BLDP streams. The huge increase in message volume on these two stocks says everything you need to know about everyone’s interest in them:

This is why you watch Sentiment and Message Volume stats on StockTwits. Look at $PLUG $BLDP: http://stks.co/h0NZQ

— StockTwits Data (@StockTwitsData) Mar. 11 at 08:29 AM

What else is trending on StockTwits? J.C. Penney, $JCP was upgraded by Citigroup. They raised their price target on the stock to $11 from $7.50. A fantastic new StockTwits user named @EconDaily shared a blog post summarizing the upgrade:

$JCP Citi Upgrades JC Penney to Buy, raises Price Target to $11 (Updated) http://stks.co/s05FS

— The Economic Daily (@Econdaily) Mar. 11 at 06:03 AM

Several great traders on StockTwits are watching National Bank of Greece, $NBG, today. In a blog post shared on the StockTwits $NBG stream yesterday, @UpsideTrader explained, “We saw the National Bank of Greece ($NBG) rip through its 50 and 200 day moving averages like a hot knife through a lamb chop”:

New Post: Chunky Monday http://stks.co/s05B3 $PLUG $NBG $IBB $REGN $HLF

— joe donohue (@upsidetrader) Mar. 10 at 05:30 PM

Biotech has been one of the hottest sectors of the year and it feels like each day there is a new company in the sector spiking 50% in less than a few hours. Today, that company appears to be La Jolla Pharmaceutical, $LJPC, which is up 60% in pre-market trading on positive test data for its kidney disease drug:

La Jolla Pharma ($LJPC) Price Target Raised at Wedbush Following Positive GCS-100 Trial http://stks.co/e0Jp2

— SIAnalystWire (@AnalystWire) Mar. 11 at 08:17 AM


Tickers: , , , ,

blog comments powered by Disqus
StockTwits Blog
  • StockTwits® is an open, community-powered idea and information service for investments. Users can eavesdrop on traders and investors, or contribute to the conversation and build their reputation as savvy market wizards. The service takes financial related data and structures it by stock, user, reputation, etc. More »

  • Search by Date

  • Join StockTwits